We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$496M
AUM Growth
+$65.1M
Cap. Flow
+$6.19M
Cap. Flow %
1.25%
Top 10 Hldgs %
46.44%
Holding
113
New
19
Increased
12
Reduced
22
Closed
15

Top Buys

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$9.04M
2
V icon
Visa
V
+$8.81M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$8.63M
4
PANW icon
Palo Alto Networks
PANW
+$8.53M
5
ANSS
Ansys
ANSS
+$8.27M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$10.8M
2
AMGN icon
Amgen
AMGN
+$9.67M
3
MRK icon
Merck
MRK
+$8.52M
4
COR icon
Cencora
COR
+$7.93M
5
MMM icon
3M
MMM
+$7.59M

Sector Composition

Rank Sector Weight
1 Healthcare 36.85%
2 Technology 22.93%
3 Industrials 11.94%
4 Communication Services 8.59%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
51
ExxonMobil
XOM
$644B
$693K 0.14%
16,807
KSU
52
DELISTED
Kansas City Southern
KSU
$674K 0.14%
3,300
TSLA icon
53
Tesla
TSLA
$1.38T
$588K 0.12%
2,499
CVS icon
54
CVS Health
CVS
$119B
$577K 0.12%
8,450
TXN icon
55
Texas Instruments
TXN
$236B
$570K 0.12%
3,475
DASTY
56
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
$515K 0.1%
2,530
+600
+31% +$122K
LSXMK
57
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$466K 0.09%
13,814
KPTI icon
58
Karyopharm Therapeutics
KPTI
$42.4M
$456K 0.09%
+1,962
New +$455K
GILD icon
59
Gilead Sciences
GILD
$181B
$446K 0.09%
7,657
VTRS icon
60
Viatris
VTRS
$18.8B
$425K 0.09%
+22,684
New +$370K
NVDA icon
61
NVIDIA
NVDA
$5.25T
$389K 0.08%
29,800
-72,200
-71% -$967K
GS icon
62
Goldman Sachs
GS
$301B
$376K 0.08%
1,425
TRIL
63
DELISTED
Trillium Therapeutics Inc.
TRIL
$365K 0.07%
+24,839
New +$358K
GLD icon
64
SPDR Gold Trust
GLD
$149B
$337K 0.07%
+1,890
New +$333K
DISH
65
DELISTED
DISH Network Corp.
DISH
$330K 0.07%
10,200
PALL icon
66
abrdn Physical Palladium Shares ETF
PALL
$741M
$321K 0.06%
+7,000
New +$308K
ITOT icon
67
iShares Core S&P Total US Stock Market ETF
ITOT
$97.4B
$302K 0.06%
3,505
MRNA icon
68
Moderna
MRNA
$55.1B
$301K 0.06%
+2,885
New +$292K
ZM icon
69
Zoom
ZM
$28.7B
$294K 0.06%
+872
New +$389K
ETSY icon
70
Etsy
ETSY
$7.67B
$285K 0.06%
+1,600
New +$241K
BRK.B icon
71
Berkshire Hathaway Class B
BRK.B
$1.08T
$272K 0.05%
1,175
IBM icon
72
IBM
IBM
$222B
$271K 0.05%
2,254
NGVT icon
73
Ingevity
NGVT
$2.39B
$243K 0.05%
+3,211
New +$209K
XLK icon
74
State Street Technology Select Sector SPDR ETF
XLK
$121B
$235K 0.05%
3,620
-3,420
-49% -$208K
LSXMA
75
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$231K 0.05%
+7,281
New +$210K

Similar funds

Private Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Private Capital Advisors held 113 positions worth $496M, up 15% from $431M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Private Capital Advisors's Q4 2020 filing shows 19 new, 12 increased, 22 reduced and 15 closed positions. Its largest new stake was Schrodinger: 143,750 shares worth $11.4M. The largest sale was Intel, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 37% a quarter earlier, followed by Technology and Industrials.

  • Private Capital Advisors's largest Q4 2020 buy was Schrodinger: 143,750 shares worth $11.4M.
  • Private Capital Advisors added most to Amazon in Q4 2020, an estimated $6.58M increase.
  • Private Capital Advisors's biggest Q4 2020 reduction was Bath & Body Works, cutting an estimated $1.94M.
  • Private Capital Advisors fully exited Intel in Q4 2020, selling an estimated $10.8M.
  • Private Capital Advisors's ten largest holdings make up 46% of its $496M portfolio in Q4 2020.
  • Private Capital Advisors opened 19 new positions and closed 15 in Q4 2020.
  • Private Capital Advisors's portfolio value rose 15% quarter-over-quarter to $496M.

Based on Private Capital Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.